Clinical Trial Update: Low-dose Gemcitabine and Cisplatin and PD-1/PD-L1 Antibody Therapy in Intrahepatic Cholangiocarcinoma [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluates low-dose gemcitabine and cisplatin with a PD-1/PD-L1 antibody in intrahepatic cholangiocarcinoma; the study is currently not yet recru…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Intrahepatic Cholangiocarcinoma

Drugs mentioned

• CISPLATIN (cisplatin)
• Gemcitabine (Gemcitabine)
• PD-1/PD-L1 antibody therapy

Snippet

Sponsor: Third Affiliated Hospital, Sun Yat-Sen University | Conditions: Intrahepatic Cholangiocarcinoma, Chemotherapy Effect | Phase 2 | Status: NOT_YET_RECRUITING